Pages that link to "Q37495759"
Jump to navigation
Jump to search
The following pages link to Metformin: a potential therapeutic agent for recurrent colon cancer (Q37495759):
Displaying 50 items.
- EMT, CTCs and CSCs in tumor relapse and drug-resistance (Q28082935) (← links)
- Chemotherapy targeting cancer stem cells (Q28085377) (← links)
- Antisense oligonucleotides against microRNA-21 reduced the proliferation and migration of human colon carcinoma cells (Q28384798) (← links)
- Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma (Q28816972) (← links)
- 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications (Q30239808) (← links)
- Role of microRNA-21 in radiosensitivity in non-small cell lung cancer cells by targeting PDCD4 gene (Q33618824) (← links)
- Use of metformin alone is not associated with survival outcomes of colorectal cancer cell but AMPK activator AICAR sensitizes anticancer effect of 5-fluorouracil through AMPK activation (Q33645356) (← links)
- Omega-3 fatty acid is a potential preventive agent for recurrent colon cancer (Q34459046) (← links)
- Buformin exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells (Q34533709) (← links)
- Metformin inhibits cell growth by upregulating microRNA-26a in renal cancer cells. (Q34547703) (← links)
- Combination of metformin and 5-aminosalicylic acid cooperates to decrease proliferation and induce apoptosis in colorectal cancer cell lines (Q35928999) (← links)
- Metformin and soybean-derived bioactive molecules attenuate the expansion of stem cell-like epithelial subpopulation and confer apoptotic sensitivity in human colon cancer cells (Q36217557) (← links)
- Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate (Q36347081) (← links)
- Metformin use and the risk of colorectal adenoma: A systematic review and meta-analysis (Q36356897) (← links)
- 5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits (Q36561571) (← links)
- Liver MicroRNA-291b-3p Promotes Hepatic Lipogenesis through Negative Regulation of Adenosine 5'-Monophosphate (AMP)-activated Protein Kinase α1. (Q36898227) (← links)
- Anti-inflammatory and Antitumor Activity of a Triple Therapy for a Colitis-Related Colorectal Cancer (Q37290538) (← links)
- Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance) (Q37496645) (← links)
- Metformin targets multiple signaling pathways in cancer (Q37609790) (← links)
- Metformin prevents hormonal and metabolic disturbances and 1,2-dimethylhydrazine-induced colon carcinogenesis in non-diabetic rats. (Q37720435) (← links)
- Cancer stem cell targeting: are we there yet? (Q38350060) (← links)
- Metformin and prostate cancer stem cells: a novel therapeutic target (Q38555403) (← links)
- Microparticulate and nanoparticulate drug delivery systems for metformin hydrochloride (Q38590960) (← links)
- Metformin Synergistically Potentiates the Antitumor Effects of Imatinib in Colorectal Cancer Cells (Q38635672) (← links)
- Management Options for Biochemically Recurrent Prostate Cancer (Q38691937) (← links)
- Metabolic Modification in Gastrointestinal Cancer Stem Cells: Characteristics and Therapeutic Approaches (Q38704618) (← links)
- The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development (Q38728567) (← links)
- A New Role for an Old Drug: Metformin Targets MicroRNAs in Treating Diabetes and Cancer (Q38758615) (← links)
- Metformin suppressed the proliferation of LoVo cells and induced a time-dependent metabolic and transcriptional alteration (Q38816034) (← links)
- Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways (Q38889490) (← links)
- Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression (Q38954232) (← links)
- Metformin treatment reduces temozolomide resistance of glioblastoma cells (Q39239705) (← links)
- The effect of rapamycin, NVP-BEZ235, aspirin, and metformin on PI3K/AKT/mTOR signaling pathway of PIK3CA-related overgrowth spectrum (PROS). (Q41233466) (← links)
- Emerging role of microRNAs in cancer stem cells: Implications in cancer therapy (Q41457379) (← links)
- Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells (Q42124995) (← links)
- Updating the research on the chemopreventive and therapeutic role of the peptide lunasin. (Q46000042) (← links)
- Metformin Mediates Protection against Legionella Pneumonia through Activation of AMPK and Mitochondrial Reactive Oxygen Species. (Q46238652) (← links)
- Drug Repurposing for the Treatment of Acute Myeloid Leukemia (Q47094576) (← links)
- The impact of metformin use on survival in prostate cancer: a systematic review and meta-analysis (Q47116201) (← links)
- Therapeutic potential of the metabolic modulator Metformin on osteosarcoma cancer stem-like cells (Q47585107) (← links)
- Effects of metformin on colorectal cancer stem cells depend on alterations in glutamine metabolism (Q47870743) (← links)
- Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells. (Q50001260) (← links)
- High-Dose Metformin Plus Temozolomide Shows Increased Anti-tumor Effects in Glioblastoma In Vitro and In Vivo Compared with Monotherapy (Q50045263) (← links)
- The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis. (Q53260164) (← links)
- Dose-Dependent Relationship Between Metformin and Colorectal Cancer Occurrence Among Patients with Type 2 Diabetes-A Nationwide Cohort Study. (Q55259169) (← links)
- Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes (Q58778156) (← links)
- Metformin reverses stem cell‑like HepG2 sphere formation and resistance to sorafenib by attenuating epithelial‑mesenchymal transformation (Q58800892) (← links)
- Combination of BEZ235 and Metformin Has Synergistic Effect on Cell Viability in Colorectal Cancer Cells. (Q64980814) (← links)
- Metformin induces miR-378 to downregulate the CDK1, leading to suppression of cell proliferation in hepatocellular carcinoma. (Q64984646) (← links)
- Temozolomide and Pazopanib Combined with FOLFOX Regressed a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse Model (Q90112553) (← links)